12:00 AM
 | 
Jan 11, 2010
 |  BC Week In Review  |  Company News  |  Deals

Benitec, Commonwealth Scientific and Industrial Research Organization deal

Benitec and CSIRO terminated their 2003 Capital Growth Agreement and Commercial Agreement for IP related to DNA-directed RNAi (ddRNAi) gene silencing technology. In exchange, CSIRO will receive a 10% equity stake in the biotech, and Benitec will retain exclusive,...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >